ISDA

Entry Detail

PDB ID:

5N7T

Keywords:

Title:

Pseudomonas fluorescens kynurenine 3-monooxygenase (KMO) in complex with 3-(5,6-dichloro-2-oxo-2,3-dihydro-1,3-benzoxazol-3-yl)propanoic acid

Biological Source:

Source Organism:

Pseudomonas fluorescens

Host Organism:

Escherichia coli

PDB Version:

Deposition Date:

2017-02-21

Release Date:

2017-06-14

Method Details:

Experimental Method:

X-RAY DIFFRACTION

Resolution:

1.81 Å

R-Value Free:

0.18

R-Value Work:

0.16

R-Value Observed:

0.16

Space Group:

P 1 21 1

Download Validation Report

Macromolecular Entities

Protein Blast

Polymer Type:polypeptide(L)
Description:Kynurenine 3-monooxygenase
Mutations:C252S C461S
Chain IDs:A, B
Chain Length:461
Number of Molecules:2
Biological Source:Pseudomonas fluorescens

UniProt ID:Q84HF5 Pfam ID:PF01494 EC:1.14.13.9

Ligand Molecules

FAD

GOL

JHY

Primary Citation

The discovery of potent and selective kynurenine 3-monooxygenase inhibitors for the treatment of acute pancreatitis.

Liddle, J, Beaufils, B, Binnie, M, Bouillot, A, Denis, A.A, Hann, M.M, Haslam, C.P, Holmes, D.S, Hutchinson, J.P, Kranz, M, McBride, A, Mirguet, O, Mole, D.J, Mowat, C.G, Pal, S, Rowland, P, Trottet, L, Uings, I.J, Walker, A.L, Webster, S.P.Show

Bioorg. Med. Chem. Lett. 27 2023 2028 (2017)

PMID: 28336141 DOI: 10.1016/j.bmcl.2017.02.078

Abstact

A series of potent, competitive and highly selective kynurenine monooxygenase inhibitors have been discovered via a substrate-based approach for the treatment of acute pancreatitis. The lead compound demonstrated good cellular potency and clear pharmacodynamic activity in vivo.

Legend

Protein

Chemical

Disease

Primary Citation of related structures